Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enterobacteriaceae, Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07318584
What this trial is testing

Cefotetan Therapy for Escherichia Coli Infections

Who this might be right for
E Coli InfectionESBL Producing E.Coli
Oregon Health and Science University 84
Not applicableLooking for participantsNCT05475574
What this trial is testing

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Who this might be right for
Infection, Hospital
Centre Hospitalier Régional Metz-Thionville 954
Not applicableStudy completedNCT04528043
What this trial is testing

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit

Who this might be right for
Critically IllEnterobacteriaceae InfectionsAntibiotic Resistant Infection
Central Hospital, Nancy, France 179
Not applicableStudy completedNCT02140502
What this trial is testing

Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy

Who this might be right for
Fluoroquinolone Resistant Enteric Bacteria
Helsinki University Central Hospital 200
Not applicableStudy completedNCT02420366
What this trial is testing

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Who this might be right for
Urinary Tract Infection, ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+2 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 257
Post-approval studies (Phase 4)UnknownNCT04608851
What this trial is testing

Preventing Urinary Tract Infections With E. Coli Nissle:

Who this might be right for
Urinary Tract Infections in ChildrenSecondary Prevention
University of Oulu 530
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Not applicableUnknownNCT05492539
What this trial is testing

Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC

Who this might be right for
Carbapenemase-Producing Enterobacteriaceae
Hospital Italiano de Buenos Aires 500
Not applicableLooking for participantsNCT04878549
What this trial is testing

Transcriptomic Responses for the Identification of Pathogens

Who this might be right for
Enteric FeverAcute Febrile IllnessTyphoid+2 more
University of Sheffield 2,000
Not applicableStudy completedNCT00573235
What this trial is testing

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Who this might be right for
Enterobacteriaceae Infections
University of Pittsburgh 300
Not applicableActive Not RecruitingNCT05870150
What this trial is testing

Challenge Non-Typhoidal Salmonella (CHANTS) Study

Who this might be right for
Salmonella InfectionsSalmonella TyphimuriumNon-typhoidal Salmonella (NTS)+5 more
Imperial College Healthcare NHS Trust 80
Early research (Phase 1)Study completedNCT01336699
What this trial is testing

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Who this might be right for
Shigella Infection
National Institute of Allergy and Infectious Diseases (NIAID) 89
Testing effectiveness (Phase 2)Study completedNCT00498654
What this trial is testing

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

Who this might be right for
Typhoid Fever
Avant Immunotherapeutics 180
Testing effectiveness (Phase 2)Study completedNCT02596308
What this trial is testing

Immunogenicity and Safety of Subunit Plague Vaccine

Who this might be right for
Plague
Jiangsu Province Centers for Disease Control and Prevention 240
Post-approval studies (Phase 4)Study completedNCT04049994
What this trial is testing

Immunomodulation Therapy for Urinary Tract Infections

Who this might be right for
Spinal Cord InjuriesUrinary Tract Infections
Swiss Paraplegic Research, Nottwil 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07666750
What this trial is testing

Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants

Who this might be right for
Shigella Infection
International Vaccine Institute 370
Early research (Phase 1)Study completedNCT02445963
What this trial is testing

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Who this might be right for
ShigellosisBacillary Dysentery
U.S. Army Medical Research and Development Command 38
Early research (Phase 1)Study completedNCT02645032
What this trial is testing

Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

Who this might be right for
Typhoid
International Vaccine Institute 144
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Post-approval studies (Phase 4)Study completedNCT00125008
What this trial is testing

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Who this might be right for
TyphoidParatyphoid Fever
International Vaccine Institute 37,673
Next Page